NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers Post Job | Search Resumes

NEWSLETTERS
Free Newsletters
Archive

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

DIVERSITY

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities


Thursday, August 28, 2008
 
Belgian Drugmaker UCB, Inc. (UCBJF.PK) to Cut 2,000 Jobs Worldwide    More...

GlaxoSmithKline (GSK) (JOBS) Signs Deal Worth Up to $820 Million with Valeant Pharmaceuticals International (VRX)    More...

Replidyne, Inc. (RDYN) to Restructure Ops, Cut 80% Jobs    More...

China Dermatology Startup, Profex Raises $15.5 Million    More...

Alkermes (ALKS) Slides on Diabetes Drug Concerns    More...

The New England Journal of Medicine Publishes Millennium's Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients; Velcade Found Better Than Standard Drug    More...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin; Primary Objective Met    More...

Zealand Pharma Appoints New Chief Executive Officer    More...

 
More Breaking News


 
 

 Market Summary

 Yesterday's Most Popular News 
August 27, 2008

Cell Genesys, Inc. (CEGE) Stops Cancer Trial on Higher Deaths More...
Amylin Pharmaceuticals, Inc. (AMLN) Reports Four Additional Deaths with Byetta More...
POINT Biomedical Corporation's Vanishing Act -- What Happened? More...
Bristol-Myers Squibb Company (BMY) (JOBS), Pfizer Inc. (PFE) (JOBS) to Delay Clot Drug after Setback More...
NexMed (NEXM) Says It Will Not File NDA for Nail Drug More...
Pain Therapeutics (PTIE) and King Pharmaceuticals®, Inc. Develop a New Abuse-Resistant Prescription Pain Medication More...
U.S. FDA Seeks More Data for Johnson and Johnson Pharmaceutical Research and Development, LLC (CA) (JOBS) Schizophrenia Drug More...
Gilead Sciences, Inc. (GILD) Plans 1,900 New Jobs; Biotech Company Moves to Double Foster City Headquarters More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) (JOBS) to Hold Byetta Call After FDA Alert More...
Solazyme, Inc. (JOBS) Adds $45 Million Series C Funding More...

U.S. Food and Drug Administation (FDA)
MedWatch

Medwatch: Two New Cases of Progressive Multifocal Leukoencephalopathy in European Patients Receiving Tysabri as Monotherapy for Multiple Sclerosis for More Than One Year 08/25/2008 More...

Medwatch: FDA Has Received Reports of 6 Cases of Hemorrhagic or Necrotizing Pancreatitis in Patients in Taking Byetta Since October 2007 08/18/2008 More...

Medwatch: Boston Scientific Corporation (BSX) NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System Product Recalled 08/14/2008 More...

CBER

CBER: Influenza Virus Vaccine 2008-2009 Season 08/27/2008 More...

CBER: Substantially Equivalent 510(k) Device Information for Biotest Diagnostics Corporation 08/22/2008 More...

CBER: Influenza Virus Vaccine 2008/2009 Season Lot Release Status - Update 08/20/2008 More...

FDA Advisory Committee Calendar

Meeting Of The Bisphenol A Subcommittee Of The Science Board To The FDA08/22/2008 More...

Meeting Of The Blood Products Advisory Committee08/22/2008 More...

Meeting Of The Advisory Committee For Reproductive Health Drugs 08/22/2008 More...

Approvals | Recalls | Discontinued | More FDA Updates